Product Program year 2025 Source: CMS Open Payments

Zymfentra

Biological Gastroenterology

NDC 72606-025-02

Open in the dashboard

General payments

$1,534,157

7,202 payments

Research payments

$0

0 payments

Through program year 2025, $1,534,157 in general payments and $0 in research payments were reported against Zymfentra (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $776,960 915
2024 General $757,197 6,287

Breakdown

Who paid General payments · program years 2024–2025
  1. Celltrion USA Inc. $1,534,157 7,202 payments
Top recipients General payments · program year 2025
  1. Jennifer Seminerio-Diehl Gastroenterology · Orlando, FL $43,201 6% · 29 payments
  2. Douglas Nguyen Gastroenterology · Mission Viejo, CA $35,582 5% · 35 payments
  3. Shadi Hamdeh Internal Medicine · Kansas City, KS $33,748 4% · 45 payments
  4. Brian Hyett Internal Medicine · Portsmouth, NH $30,936 4% · 27 payments
  5. Aja McCutchen Gastroenterology · Winder, GA $30,018 4% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $532,894 72% · 165 practitioners
  2. Pediatric Gastroenterology Pediatrics $88,962 12% · 18 practitioners
  3. Internal Medicine $71,027 10% · 12 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $29,335 4% · 41 practitioners
  5. Nurse Practitioner $6,551 <1% · 11 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $99,648 13% · 71 recipients
  2. California $93,441 12% · 62 recipients
  3. New York $86,301 11% · 24 recipients
  4. Illinois $60,951 8% · 13 recipients
  5. Maryland $54,812 7% · 9 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

7,202 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record